...
首页> 外文期刊>EFSA Journal >Scientific Opinion on the substantiation of health claims related to sodium phosphate and increase in endurance performance (ID 318, 2887) and increase in endurance capacity (ID 318, 2887) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
【24h】

Scientific Opinion on the substantiation of health claims related to sodium phosphate and increase in endurance performance (ID 318, 2887) and increase in endurance capacity (ID 318, 2887) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

机译:根据1924/2006号法规(EC)第13(1)条,关于与磷酸钠有关的健康主张的依据的科学意见,以及耐力性能的提高(ID 318,2887)和耐力的提高(ID 318,2887)

获取原文
   

获取外文期刊封面封底 >>

       

摘要

This opinion addresses the scientific substantiation of health claims in relation to sodium phosphate and increase in endurance performance and increase in endurance capacity. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The food constituent that is the subject of the health claims is sodium phosphate. The Panel considers that sodium phosphate is sufficiently characterised. Increase in endurance performance The claimed effects are “supports an increase in performance during maximal aerobic exercise lasting 10 minutes or longer” and “supports an increase in VO2 max”. The target population is assumed to be adults performing endurance exercise. In the context of the proposed wordings, the Panel assumes that the claimed effects refer to increase in endurance performance. The Panel considers that an increase in endurance performance is a beneficial physiological effect. In weighing the evidence, the Panel took into account that the one human intervention study provided from which conclusions could be drawn for the scientific substantiation of the claim did not show an effect of sodium phosphate on endurance performance. 1 On request from the European Commission, Question No EFSA-Q-2008-1105, EFSA-Q-2008-3620, adopted on 08 April 2011. Panel members: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus L?vik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuh?user-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen.
机译:该意见涉及与磷酸钠有关的健康主张的科学依据,以及耐力性能的提高和耐力的提高。科学依据是成员国在第13条健康声明综合清单中提供的信息,以及EFSA从成员国或直接从利益相关者那里获得的参考。健康声明所涉及的食物成分是磷酸钠。小组认为,磷酸钠具有足够的特征。增强耐力性能所宣称的效果是“支持持续10分钟或更长时间的最大有氧运动时性能的提高”和“支持VO2 max的提高”。假定目标人群是进行耐力运动的成年人。在提议的措词范围内,小组认为所要求的效力是指提高耐力表现。小组认为,提高耐力表现是有益的生理作用。在权衡证据时,小组考虑到提供的一项人为干预研究可从中得出结论以对索赔进行科学证实,但并未显示出磷酸钠对耐力表现的影响。 1应欧洲委员会的要求,于2011年4月8日通过,编号EFSA-Q-2008-1105,EFSA-Q-2008-3620。 ,Ines Golly,Hannu Korhonen,Pagona Lagiou,Martinus L?vik,Rosangela Marchelli,Ambroise Martin,Bevan Moseley,Monika Neuh?user-Berthold,Hildegard Przyrembel,Seppo Salminen,Yolanda Sanz,Sean(JJ)Strain,Stephan Strobel,Inge Tetens,DanielTomé,Hendrik van Loveren和Hans Verhagen。

著录项

  • 来源
    《EFSA Journal》 |2011年第6期|共15页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类 食品工业;
  • 关键词

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号